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ABSTRACT
HIGH DIVERSITY OF TRYPANOSOMA CRUZI DISCRETE TYPING UNITS
CIRCULATING IN TRIATOMA IN WESTERN MEXICO
by
Uyen Tran Thuong Nguyen
November 2016
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi, which is
transmitted to domestic and sylvatic mammals via the feces of hematophagous hemiptera
of the subfamily Triatominae (Reduviidae). Trypanosoma cruzi is found only in the
Americas and displays remarkable genetic diversity. Seven discrete typing units (DTUs)
are currently recognized (TcI–TcVI and TcBat). In Jalisco, Mexico, where Chagas
disease has a high prevalence rate, TcI has historically been the only DTU reported. This
study focused on the molecular identification of T. cruzi DTUs circulating in Triatoma
near the Estación de Biología Chamela, on the southwest coast of Jalisco, Mexico. I
collected DNA from 95 Triatoma bugs. Trypanosoma cruzi infection was detected using
PCR primers specific for the minicircle variable region of the parasite’s kinetoplast DNA
(kDNA). Trypanosoma cruzi DTUs were identified by amplifying the intergenic region
of the mini-exon, and the genes 24Sα, 18S, TcSC5D, and TcMK. Two species of Triatoma
were collected, Triatoma longipennis and T. bolivari, with an overall infection rate of
59%. There was high genetic diversity of T. cruzi in my samples, with the DTUs TcI,
TcII, TcIV, TcVI, and Tcbat being identified. This is the first report of TcVI and Tcbat in
North America. In the Triatoma found to be infected, 96% had TcI, 35% TcII, 2% TcIV,
iii

25% TcVI, and 2% Tcbat. Several vertebrate hosts for Triatoma were also identified
from visible blood within Triatominaes’ gut using PCR primers for cytochrome b and
cytochrome oxidase subunit I genes. My observations indicate a much higher diversity of
T. cruzi DTUs in Triatoma than previously reported in Jalisco. The results have important
implications for understanding the geographical distribution of T. cruzi DTUs and
epidemiology of Chagas disease in Mexico.
Keywords: Trypanosoma cruzi, Genotyping, Discrete typing units (DTUs), Triatoma
longipennis, Triatoma bolivari, Seasonally dry tropical forest, Jalisco, Mexico.
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CHAPTER I
INTRODUCTION
Chagas disease (American trypanosomiasis) is caused by infection with Trypanosoma
cruzi, a parasitic protozoan found in mammals wherever Triatominae insect vectors are found,
between approximately 40o N and S of the equator in the Americas ("Who, how, what and
where ?" 2010). Chagas disease is listed by WHO as one of the top 17 most neglected tropical
diseases that is caused by bacterial and parasitic infection, alongside ascariasis, trichuriasis,
hookworm infection, leishmanisasis, and human African trypanosomiasis (Molyneux et al.
2016). Chagas disease is responsible for disability and early death in approximately one-third of
those infected (Carabarin-Lima et al. 2013). The WHO reports that approximately 5-6 million
individuals are infected with Chagas disease, more than 25 million are at risk, and 10,000 die
each year in endemic areas (WHO 2010; 2015). Chagas disease has been increasingly detected in
the US, Canada, and many European and Asian countries due to human migration between Latin
America and the rest of the world (Coura and Viñas 2010).
In Mexico, it is estimated that 1.1 to 2 million people are infected with Chagas disease,
predominately through vector-borne exposure (Carabarin-Lima et al. 2013). Trypanosoma cruzi
infection has also increasingly been transmitted via blood transfusion(Carabarin-Lima et al.
2013), although mandatory serological screening nationwide is reducing this risk (SánchezGonzález et al. 2016). In addition, there is no consensus on diagnostic methods and trypanocidal
treatment is not administered to chronic patients (Carabarin-Lima et al. 2013). The disease is also
becoming more urbanized due to human migration from rural areas to Mexican cities, mostly in
search of jobs (Guzmán-Bracho 2001). There are 18 regions in Mexico, all rural, that have
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endemic T. cruzi transmission, including the states of Oaxaca, Jalisco, Yucatan, Chiapas,
Veracruz, Puebla, Guerrero, Hidalgo, and Morelos (Carabarin-Lima et al. 2013).
Due to a high genetic diversity, Trypanosoma cruzi is classified into 7 strains, known as
discrete typing units (DTUs), namely TcI, TcII , TcIII , TcIV , TcV , TcVI, and Tcbat (Zingales
et al. 2012). The dominant strain of T. cruzi in Mexico is TcI (Bosseno et al. 2002; Brenière et al.
2007), but recent studies have indicated other DTUs (TcII, III, IV, V) circulating in Triatominaes
in Veracruz and Michoacán, Mexico (Ramos-Ligonio et al. 2012; Ibáñez-Cervantes et al. 2013).
One study also reported many patients in Mexico were seropositive for TCII, which includes
DTUs TcII-VI (Risso et al. 2011). These studies suggest either that the diversity of T. cruzi
strains in Mexico is growing, or increased sampling has led to a better understanding of the
complexity of DTUs within Mexico.
Jalisco has the highest prevalence of T. cruzi infection in Mexico, as 12% of the
population was found to be seropositive (Carabarin-Lima et al. 2013), and only TcI has been
previously reported there (Bosseno et al. 2002; Brenière et al. 2007). However, Jalisco is
adjacent to Michoacán, where multiple T. cruzi DTUs have been identified (Ibáñez-Cervantes et
al. 2013). Given these findings, Jalisco could potentially have greater diversity of T. cruzi DTUs
than previously reported.
My study explores the prevalence and diversity of potential T. cruzi DTUs within their
sylvatic Triatoma insect vectors inhabiting a tropical dry forest reserve in coastal Jalisco,
Mexico. My objectives were to (a) evaluate the prevalence of T. cruzi in the local Triatominae,
(b) determine the T. cruzi DTUs and haplotypes present in the region, (c) identify Triatominae
vectors encountered near Estación de Biología Chamela (EBCh) in Jalisco, Mexico, and (d)
when possible, determine which vertebrates are serving as hosts for Triatominae.
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CHAPTER II
LITERATURE REVIEW
Brief Background
Trypanosoma is a genus in the class Kinetoplastida, and a monophyletic group of
flagellated protozoa that is exclusively parasitic. Several trypanosomes cause serious disease in
humans, Trypanosoma brucei gambiense and T.b. rhodesiense cause African trypanosomiasis
(sleeping sickness), while Trypanosoma cruzi causes American trypanosomiasis (Chagas
disease). Chagas disease was discovered by a Brazilian scientist Carlos Chagas (1879-1934) in
1909. He found a flagellated parasite in the intestine of a blood-sucking (hematophagous) bug
and he named it T. cruzi after his mentor Oswald Cruz, the founder of the Oswaldo Cruz Institute
in Brazil (Junqueira et al. 2010). After his discovery of Chagas disease, significant progress has
been made in many aspects of this disease, including increased understanding of its
epidemiology, parasite genome, immunology, and host-parasite interactions (Junqueira et al.
2010). However, it is still a serious public health concern in Latin America and non-endemic
areas due to human migration (Brener and Gazzinelli 1997; El-sayed et al. 2005).
Chagas disease is transmitted to humans and mammals by blood-sucking bugs, which
belong to the subfamily Triatominae (Hemiptera: Reduviidae). The disease is found in wildlife
anywhere the vectors are found, from Argentina up to approximately 40o North latitude in the
Americas (2010). These bugs are attracted to warmth and CO2 exhaled from mammals; therefore
they usually bite the victims near their mouth at night while sleeping. Because of this, they have
been nicknamed kissing bugs. Other common names are conenose bug, assassin bug, and
triatomine bug. There are more than 130 species of kissing bugs, but only a few are known
vectors for Chagas disease (Lent and Wygodzinsky 1979). Charles Darwin, in Voyage of the
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Beagle, described being bitten by a kissing bug during his field trips to the Argentine pampas
(Rassi et al. 2010). He later suffered debilitating symptoms consistent with Chagas disease
infection (Rassi et al. 2010). Interestingly, T. cruzi DNA has been found in 9000-year-old
mummified human tissues in northern Chile; the disease is believed to have been in the New
World for 7-10 million years, long before humans migrated into the Americas (Aufderheide et al.
2004; Steverding 2014).
Morphology and Life Cycle
Trypanosoma cruzi is a eukaryotic single-celled flagellate. Besides having a nucleus, it
possesses a single large and highly modified mitochondrian containing a network of circular
DNA (called kinetoplast DNA or kDNA) that contain many copies of the mitochondrial genome.
T. cruzi transitions between three different forms (epimastigote, trypomastigote, and amastigote)
in its life cycle when it travels from its vector (kissing bugs) to its mammalian host (Fig. 1). The
epimastigote and trypomastigote have a single flagellum that enables movement and attachment
to the surface of the host cell (De Souza 1999). Epimastigotes are found in the intestinal tract of
kissing bugs, are about 20 microns in length, and divide via binary fission. Its kDNA is
positioned in the middle of the body, adjacent to the base of the flagellum posteriorly, and to
nucleus anteriorly. Trypomastigotes are found in the blood stream of infected hosts. They are 1525 microns in length and do not divide. Its kDNA is found at the most posterior portion of its
body, adjacent anteriorly to the base of flagellum. The nucleus is found in the middle of the
body. It has a characteristic C-shape if stained with Giemsa stains. Amastigotes live
intracellularly, lack a flagellum and are among the smallest known eukaryotic cells (2.5–5 μm
wide). Amastigotes are found within the cytoplasm of nucleated cells in their mammalian hosts.
This stage is oval and is the dividing form within mammals.
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Fig. 1 Schematic illustration of Trypanosoma cruzi stages. Morphological differences included
the size of each stage and the location of kDNA, nucleus, and flagellum. (A) Epimastigote, (B)
Trypomastigote, (C) Amastigote (Schuster and Sullivan 2002).
The life cycle of T. cruzi starts when a kissing bug takes a blood meal from an infected
mammalian host (Fig. 2). Blood containing trypomastigotes is ingested by the insect vector. The
trypomastigotes transform into epimastigotes in the digestive tract of the bug. Epimastigotes
differentiate into metacylic trypomastigotes in the feces of the kissing bug. During the blood
meal, the infected bug defecates on the host, releasing highly infective parasites onto the source
of the bloodmeal. The parasites are not passed by the bite itself. Metacylic trypomastigotes in the
defecant enter the mammalian host’s body through the bite wound, broken skin, or intact
mucosal membranes. Inside the host, trypomastigotes enter the host nucleated cells and
transform into a dividing form, amastigotes. Amastigotes mutiply inside the host cell until it
ruptures, allowing them to invade other healthy cells.
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Fig. 2 Life cycle of Trypanosoma cruzi (Centers for Disease Control and Prevention 2015).
Chagas Disease
Acute phase
There are three phases of Chagas infection: acute, indeterminate, and chronic phases. The
acute phase occurs after T. cruzi enters the victim’s body and lasts for 4-8 weeks (Rassi et al.
2010). Most cases will pass unnoticed because the clinical symptoms are nonspecific and typical
for many infections. Victims have flu-like symptoms, such as fever, nausea, vomiting, and
diarrhea. An inflammatory lesion at the T. cruzi entry site (chagoma) and enlarged lymph nodes,
liver, and/or spleen may be observed in the acute phase. If the entry point is the eye, it may cause
swelling of the eye (Romana’s sign) and conjunctivitis. Circulating trypomastigotes in blood are
easily found during the acute phase. Acute infection can be cured with antiparasitic drugs such as
benznidazole and nifurtimox (Rassi et al. 2010). Death may occur (<5-10%) in acute infected
6

individuals, often in children (4 years old or younger), from severe myocarditis and/or
meningoencephalitis (Rassi et al. 2010).
When Chagas disease is transmitted congenitally by an infected mother during
pregnancy, infected new born babies may develop acute symptoms at birth or a few weeks after
birth, including hypotonicity, fever, hepatosplenomegaly, anemia, prematurity, low birth weight,
and low Apgar score (Rassi et al. 2010). Miscarriage and placentitis can also occur during
pregnancy due to maternal infection (Rassi et al. 2010).
Intermediate and chronic phases
After 8-12 weeks of the initial infection, the parasitemia becomes undetectable by
microscopy and, without appropriate treatment, infected individuals will enter the intermediate
form of Chagas disease (Bern et al. 2011). Patients may have a positive serological test, but
never develop any clinical manifestations, and the parasite will be maintained for life (Machado
et al. 2012). In some cases, individuals might not be aware of their infection but remain a
potential source of T. cruzi transmission to vectors and humans (Bern et al. 2011).
Approximately, 30%-40% of infected individuals will develop the chronic phase of
Chagas disease, which occurs 10-30 years after the initial infection (Rassi et al. 2010). Pathology
of chronic Chagas disease, involved in heart, esophagus and colon, is classified into three clinical
manifestations: cardiac, digestive and cardiodigestive. Digestive form of chronic Chagas disease
is often observed in southern cone of South America and is rarely found in northern South
America and Central America (Bern et al. 2011). Geographic distribution of disease pathology
may be associated with different strains of T. cruzi. However, it has not been established which
strain leads to which disease pathology of Chagas disease. Physiological factors of hosts, such as
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genetic background, mitochondrial dysfunction, and immune competence, may be involved in
the outcomes of clinical manifestation (Machado et al. 2012).
The digestive form occurs in 10-15% of those with chronic Chagas disease and is mainly
found in the southern cone of South America: Argentina, Brazil, Chile, and Bolivia (Rassi et al.
2010). In the digestive form, T. cruzi injures the enteric nervous system, which regulates the
function of gastrointestinal (GI) tract, resulting in dilation of organs of the GI tract (Machado et
al. 2012). Although the enlargement of esophagus (megaoesophagus) and colon (megacolon) are
the most common manifestations, enlargement of stomach, duodenum, jejunum, gallbladder, and
choledochus are observed in some cases (Machado et al. 2012). Megaoesophagus causes
difficulty in swallowing, regurgitation, excess salivation and malnutrition (Rassi et al. 2010).
Megacolon, often occurring at the sigmoid segment, rectum, and descending colon, causes
prolonged constipation, abdominal distension, and bowel obstruction (Rassi et al. 2010). Patients
with megaoesophagus are more likely to develop esophagus cancer. However, colon cancer is
not associated in patients with megacolon (Rassi et al. 2010). These clinical manifestations can
ultimately lead to death in severe cases (Rassi et al. 2010).
The cardiac form occurs in 20-30% of individuals with chronic phase and is the most
serious manifestation of chronic Chagas disease. Pathogenesis is not completely understood but
believed to be due to parasite persistence (Bern 2015). Cardiomyopathy, the main manifestation
of cardiac form, is characterized by a chronic inflammatory process of the heart, including all
chambers and the conduction system (Bern et al. 2011). To infect the heart, trypomastigotes must
pass through layers of extracellular matrix (ECM) to reach cardiac myocytes. Invasion by T.
cruzi results in myocardial damage, such as ischemia, inflammation, oxidative stress, and
necrosis, which leads to ECM degradation (Machado et al. 2012). The earliest signs of affected
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patient are often conduction-system abnormalities and multiform premature ventricular
contraction (Bern 2015). Patients also display symptoms of cardiomyopathy, including sinus and
junctional bradycardias, atrial fibrillation, atrioventricular blocks, and non-sustained or sustained
ventricular tachycardia (Bern 2015). As the disease progresses, dilated cardiomyopathy and
congestive heart failure might occur. These symptoms lead to palpitation, presyncope, and risk of
sudden death. Apical aneurysm is a the hallmark of chronic Chagas disease and is believed to be
a result of ECM degradation (Machado et al. 2012). In addition, strokes and thromboembolic
events may occur as a result of the dilated left ventricle or aneurysm (Bern et al. 2011). Sudden
death is typical in advanced cardiomyopathy and accounts for more than half of deaths (5565%), followed by heart failure, and thromboembolism (Rassi Jr et al. 2001). Thromboembolism
can cause pulmonary and arterial embolization as well as stroke. Unexpected sudden death can
also occur in patients with the indeterminate form of chronic Chagas disease, who do not have
knowledge of their infection (Rassi Jr et al. 2001).
Innate and Adaptive Immune Responses During T. cruzi Infection
Innate and adaptive immune responses are two important parts of the human immune
system. As its name suggests, the innate immune response consists of cells and proteins that
humans are born with. It is responsible for non-specific defense mechanisms that will protect the
body immediately against pathogens. The adaptive immune response is an antigen-specific
mechanism and is initiated when the innate immune response fails to fight off the pathogen.
Once a specific pathogen (antigen) is recognized and processed, the body will build up an army
of specialized immune cells to overcome that specific pathogen. During the course of T. cruzi
infection, the innate and adaptive immune systems play an important role for host survival and
control of the parasite load.
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Initial interaction of T. cruzi and host cells
Metacyclic trypomastigotes have the ability to invade any nucleated host cells. Once they
penetrate the human body through broken skin or mucosal membranes, they encounter host
tissue cells and immune cells, but have a preference to invade non-phagocytic cells rather than
immune cells (Padilla et al. 2009). This allows the trypomastigotes to avoid the early immune
response present in the blood, allowing the persistence of acute Chagas infection (Padilla et al.
2009). The parasite gains entry to the host cells in two ways: lysosome-dependent route or
invagination of plasma membrane and fusion with lysosomes (Tardieux et al. 1992; Rodríguez et
al. 1995; Rodríguez et al. 1996; Woolsey et al. 2003; Andrade and Andrews 2004). In both cases,
it is confined to the host cell lysosome. A parasite-containing lysosome is called a
parasitophorous vacuole. Lysosome fusion is necessary for a successful infection and
trypomatigote-amastigote transformation (Woolsey et al. 2003; Andrade and Andrews 2004).
The low pH environment of parasitophorous vacuoles activates a surface protein of the parasite
called trans-sialidase. In the active form, trans-sialidase removes sialic acid, which is a
protective coating on the inner layer of the parasitophorous vacuole and maintains the acidic
environment. The absence of sialic acid ruptures the parasitophorous vacuole and releases
trypomastigotes to the cytoplasm (Hall et al. 1992; Albertti et al. 2010). In the cytoplasm, the
trypomastigotes transform into amastigotes. After several rounds of amastigote replication the
infected cell bursts, releasing the parasites and allowing them to infect neighboring cells or travel
in the blood stream to other parts of the body.
Pattern-recognition receptors
Pattern-recognition receptors (PRRs) are one of the first lines of host defense against T.
cruzi and are expressed by cells of the innate immune response (Gazzinelli and Denkers 2006).
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PRRs recognize the molecules of the pathogen, also called pathogen associated molecular
patterns (PAMPs). Toll-like receptors (TLRs) are specialized types of the PRRs and are located
at either the cell surface or within the endosome. They are mainly expressed by antigenpresenting cells, such as macrophage and dendritic cells. Binding of TLRs to PAMPs triggers the
MyD88-dependent signaling cascade, which induces the activation of transcription factor NF-kB.
Activated NF-kB diffuses into the cell nucleus and activates transcription of proinflammatory
cytokines and chemokines, leading to the recruitment of phagocytic cells to the infected site as
well as initiating the adaptive immune response. T. cruzi has several molecules that activate
different TLRs, such as the mucin, glycoinositophospholipid (GIPL), and T. cruzi DNA and
RNA. Mucin is a glycosylphosphatidylinositol (GPI)-anchored surface protein of T. cruzi
(Almeida and Gazzinelli 2001). It binds and activates TLR2/TLR6, leading to the production of
cytokines IL-12, TNF, and nitric oxide. GIPLs are free GPI anchors present in all forms of T.
cruzi; they bind to and activate TLR4, leading to increased cytokine production. IL-12 also
activates natural killer cells (NK). NK cells are cytotoxic and are able to kill parasite-infected
cells. NK cells also activate macrophages by inducing production of the cytokine IFN-
(Gazzinelli and Denkers 2006).
Unlike TLR2/TLR6 and TLR4, TLR7 and TLR9 are located on the intracellular
membrane of endosomes and are activated by binding T. cruzi DNA and/or RNA molecules.
Activation of TLR7 and TLR9 stimulates the production of Th1 proinflammatory cytokines
(Cardoso et al. 2016). Nucleotide-binding oligomerization domain (Nod)-like receptors (NLR)
are another type of PRRs and located in the cytoplasm of the cell. Studies show that NLRs are
involved in controlling T. cruzi infection. However, the mechanism of NLRs is still unknown
(Cardoso et al. 2016).
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Complement system and T. cruzi infection
As the infected cell bursts, T. cruzi parasites enter the blood stream and encounter the
complement system of the innate immune response. The complement system consists of three
pathways: classical, alternative, and lectin. All pathways produce C3 convertase and C5
convertase, which lead to formation of the membrane attack complex (MAC). MAC forms pores
in the lipid bilayer and lyses the parasites. The lectin pathway is activated by binding of mannanbinding lectin (MBL), H-ficolin, and L-ficolin to the surface of T. cruzi, and is responsible for
approximately 70% of parasite lysis (Cestari et al. 2009; Cestari and Ramirez 2010; Cestari et al.
2013). The alternative pathway is activated by spontaneous cleavage of C3 to C3a and C3b
(Cestari and Ramirez 2010). Anti-T. cruzi antibody is produced by immune cells and binds to the
surface proteins of T. cruzi. This antibody then binds the C1 molecule and activates the classical
pathway. To overcome defensive mechanisms of complement pathways, T. cruzi possess a group
of molecules that prevent the activation of these pathways. For instance, calreticulin, a T. cruzi
surface protein, interacts with several molecules of the lectin and classical pathways to prevent
the formation of C3 and C5 convertases (Ferreira et al. 2004). T. cruzi complement regulatory
protein (CRP), also known as GPI-anchored surface protein, binds to molecules involved in the
initial steps of the classical and alternative pathways to render them inactive (Norris et al. 1991;
Norris 1998). T. cruzi transmembrane protein, known as complement C2 receptor inhibition
trispanning (CRIT), blocks the formation of C3 convertase in the lectin and classical pathways
(Cestari et al. 2008; Cestari et al. 2009). In summary, T cruzi has diverse molecules that can
disrupt the complement system, preventing the formation of C3 convertase, a key factor to
parasite lysis. In addition, C3b molecule is produced by C3 convertase and is an opsonin, which
enhances the phagocytosis of pathogens. Without C3 convertase, C3b molecule is not formed
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and therefore prevents the phaygocytosis or lysis of T. cruzi. In addition, a study shows that T.
cruzi triggers the release of host plasma membrane-derived vesicles, which inhibit the initial
steps of classical and lectin pathways and facilitates the invasion of T. cruzi (Cestari et al. 2012).
Adaptive immunity against T. cruzi infection and immunodominance
Activation of TLRs not only activates the production of cytokines but also bridges the
innate and adaptive immune responses. One of the hallmarks of an immunological response of
adaptive immunity against T. cruzi infection is a strong and persistent T helper 1 (Th1) response
as well as activating CD8+ T cells. Th1 response is dependent on the TL7/TL9 activation
(Junqueira et al. 2010). Activated Th1 cells produce IFN- which activate macrophages and B
cells, whose function is to produce specific antibodies for T. cruzi lysis and opsonization. T.
cruzi also induces the production of IL-10, which triggers T helper 2 response. The cytokine IL10 is known to inhibit the activation of Th1 immune response; therefore, activation of IL-10 is
crucial for parasite survival (Geiger et al. 2016). In addition, the presence of T.cruzi causes
intense polyclonal B cell activation, which is not specific for parasite antigens, and therefore may
delay a parasite-specific humoral response (Cardoso et al. 2016).
In the infected cell, T. cruzi antigens are released in the cytosol, either from the parasite
shedding or parasite lysis, will become available for processing and presentation by the major
histocompatibility complex (MHC) class I. Although, CD8+ T cells could potentially bind many
T. cruzi antigens, they appear to preferentially recognize only a few T. cruzi epitopes, a process
called immunodominance (Junqueira et al. 2010). Due to their abundance and high affinity to
MHC and T cell receptor, the trans-sialidase and amastigote surface proteins are two important
immunodominant antigens during T. cruzi infection (Junqueira et al. 2010; Cardoso et al. 2016).
Studies suggest that immunodominance interferes with a broad recognition of T.cruzi antigens,
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rendering the immune response unable to eradicate T. cruzi and leading to persistent infection
and subsequent chronic Chagas disease (Rodrigues et al. 2009).
Epidemiology
There are two main transmission cycles of Chagas disease: wild (sylvatic) transmission
cycle, occurring in wild kissing bugs and wild animals, and domestic transmission cycle,
occurring in humans and household animals if kissing bugs live in human dwellings (homedwelling kissing bugs). Peridomestic cycle is originated from both domestic and wild cycles,
maintained by wild kissing bugs and domestic animals and occurs in areas surrounding human
dwellings (Coura and Dias 2009). Chagas disease mainly occurs in developing countries with
substandard rural housing and new urban or peri-urban areas, which allow infestation with the
kissing bugs. Those infected often live in homes with mud walls and/or thatched roofing. If the
kissing bugs inhabit the thatch roof, their feces may rain on the household items and food.
There are more than 180 wild mammalian species known to serve as T. cruzi reservoirs,
including marsupials, xenarthra, bats, carnivores, lagomorphs, rodents, and non-human primates
(Coura and Dias 2009). Domestic reservoirs are primarily dogs, cats, rats, mice, and cattle.
Others animals, such as birds, reptiles, and fish could provide a blood meal for triatomine
vectors. However, only mammals are known to support T. cruzi infection. The parasite’s ability
to survive in mammals is due in part to its expression of complement inhibitors that subvert
innate immunity (Tambourgi et al. 1993; Norris 1998; Atayde et al. 2004; Cestari et al. 2008).
Vectors of T. cruzi are from the Reduviidae family (or subfamily Triatominae), mainly
from the genera Triatoma, Rohdnius and Panstrongylus, with T. infestans, T. dimidiata, R.
proxilus, and P. megistus being the most important vectors (Rassi et al. 2010; Carabarin-Lima et
al. 2013). Most species are found from southern Argentina up to 40º North latitude in the United
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States and from sea level up to 1500 meters of altitude (WHO 2002). Triatomines are nocturnal,
have 5 nymphal stages, and adults of two sexes. They rely on blood exclusively for development
and egg production. The probability of triatomines infected with T. cruzi is proportional to the
number of blood meal taken. Therefore, older triatomines tend to have higher chances of having
T. cruzi infection (Rassi et al. 2010). T. infestans is almost exclusively associated with human
dwellings and is the main vector in the southern cone of South America, such as Uruguay, Chile,
Brazil, and Argentina (WHO 2002; Vazquez-Prokopec et al. 2009; Rassi et al. 2010). R. proxilus
is mainly found in Central America and northern South America (Rassi et al. 2010). Distribution
of T. dimidiata is similar to R. proxilus but also extends to North America, including Mexico
(Rassi et al. 2010). P. megistus is reported in South America and is the most important Chagas
disease vector in Brazil (WHO 2002; Ribeiro et al. 2015).
Vector-borne transmission is the predominant route of infection with T. cruzi. However,
organ transplantation, blood transfusion, ingestion of infected kissing bugs, T. cruzi–
contaminated foods/liquids, and working in laboratories with live T. cruzi, are also potential
routes of infection (Rassi et al. 2010). The infection can also occur congenitally via placenta and
in ingestion of breast milk of an infected mother (Rassi et al. 2010; Steverding 2014).
Furthermore, research demonstrating T. cruzi in gonads of mice suggests that Chagas disease
could potentially be transmitted through sexual intercourse (Carvalho et al. 2009).
Even though Chagas disease is a major public health problem in endemic countries, little
is known of the distribution of this disease in non-endemic areas. Chagas disease has been
increasingly detected in the USA, Canada, and many European and Asian countries, due mainly
to migration between Latin America and the rest of the world. Based on the immigration rate
from Latin America to the USA and the prevalence of the disease, it is estimated that more than
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300,000 individuals in the USA are infected with T. cruzi and more than half originated from
Mexico. Since blood donation screening for T. cruzi started in 2009, 2,183 cases have been
detected with T. cruzi infection in all states of the US except Wyoming and South Dakota (2016).
In non-endemic areas, the main transmission mode is through transplantation, blood transfusion,
and birth.
Diagnosis
Diagnosis of Chagas infection is accomplished with several different methods, which are
used according to the phases of Chagas infection. During the acute phase, the parasitemia
(circulating trypomastigotes in blood) is high and is easily detected in an anticoagulated blood or
buffy coat by microscopic examination (Bern et al. 2007; Messenger et al. 2015).
Trypomastigotes in blood are also visualized by staining with Giemsa or other stains and can be
grown in specialized media in the laboratory (Bern 2015). Parasitemias decreases 2-3 months
after infection, even without treatment, so microscopic examination is not accurate for patients
with chronic infection. Since T. cruzi can be transmitted from chronically infected patients
(blood transfusion, organ transplantation, and congenital infection) due to undetected infections,
accurate diagnosis is critical (Bern 2015). Polymerase chain reaction (PCR) is a very sensitive
diagnostic tool for the acute phase, congenital infection, and for recipients of an infected organ
(Bern et al. 2011).
During the chronic phase, several serological tests are used to detect the presence of IgG
antibodies against T. cruzi antigens, such as enzyme-linked immunosorbent assay (ELISA) or
indirect and direct immunofluorescent antibody assays (IFA) (Bern 2015). Two serological tests
are often required for a conclusive result. When results are different, a third test is used to
confirm or disprove the diagnosis. Assays used as reference tests do not have high sensitivity and
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accuracy for diagnosis, including radioimmunoprecipitation assay (RIPA) and trypomastigote
excreted-secreted antigen immunoblot (TESA-blot) (Bern et al. 2011). Studies show that
different T. cruzi strains possibly affect the sensitivity of serological tests (Bern et al. 2011).
Treatment and Control
There are two treatment options for Chagas disease: antitrypanosomal and symptomatic
treatments (Bern et al. 2007). Antitrypanosomal treatment seeks to eradicate the parasites living
in the patient’s tissues. Benznidazole and nifurtimox are widely used as anti-parasitic drugs and
are recommended for acute, congenital, and reactivated infections in individuals who have
become immune-suppressed (Bern et al. 2011). These are offered to patients with chronic
infections at the age of 18 or older (Bern et al. 2007). In the 1990s, studies found that
benznidazole show 60% efficacy in chronic Chagas disease patients in treatment trials (de
Andrade et al. 1996; Estani et al. 1998). Studies also show that benznidazole treatment prevents
the progression of cardiomyopathy and decreases mortality in chronically infected adults (Viotti
et al. 1994; Viotti et al. 2006).
Symptomatic treatment does not involve killing parasites, but lessening the cardiac and
digestive manifestations that occur later in the chronic phase. For cardiac symptoms, single or
several treatments may be used to prevent further complications, including medications,
pacemaker, devices to regulate heart rhythm, or surgery (Rassi et al. 2010). Amiodarone has
been widely used for patients with irregular heart rhythm and myocardial dysfunction. In severe
cases, implantable cardioverter defilbrillators (ICDs) are also used. Patients with
bradyarrhythmia (slow heart rate) are treated with medication and/or pacemaker. Treatment of
gastrointestinal symptoms may include medication, diet, corticosteroids, or surgery (Rassi et al.
2010). Patients with megaoesophagus would have food and liquid deposited directly to the
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stomach; in severe cases, esophagectomy is used. An early stage of colonic symptom can be
treated with rich-fiber diet and abundant fluid intake, laxative, or enema. Patients with severe
cases will undergo surgical organ resection.
A vaccine has not been developed for Chagas disease. The main focus of prevention is
through vector control and prevention of non-vector borne transmission (Rassi et al. 2010).
Application of insecticide is extensively used in triatomine-infested houses and endemic regions,
as well as house improvement and health education. Screening of blood donors prevents T. cruzi
transmission through organ transplantation and blood transfusion.
Genetic Diversity of T. cruzi
Trypanosoma cruzi is believed to have spread throughout the Americas by bats and is a
clonal species, dividing by binary fission (Steverding 2014). This parasite was classified into two
major lineages, T. cruzi I (TCI) and T. cruzi II (TCII). TCII has been further subdivided into five
groups: IIa, IIb, IIc, IId, and IIe (Zingales et al. 2009). Recently, the lineages have been revised
and classified into seven discrete typing units (DTUs), namely TcI (TCI), TcII (IIb), TcIII (IIc),
TcIV (IIa), TcV (IId), TcVI (IIe), and the most recently proposed Tcbat (Marcili et al. 2009;
Zingales et al. 2012). TcV and TcVI are hybrids of TcII and TcIII (Machado and Ayala 2001;
Westenberger et al. 2005; De Freitas et al. 2006; Lewis et al. 2011). These hybrids may have
arisen from two independent recombination events or a single incidence of hybridization
followed by clonal divergence (Lewis et al. 2011). Tcbat, considered to be a bat-exclusive
lineage of T. cruzi, has not been reported north of Panama (Breniere et al. 2016). Tcbatw is
closely related to TcI and can be mistaken for TcI using standard molecular identification (Lima
et al. 2015). It has been suggested that different DTUs cause different disease pathology of
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Chagas disease, but it is unknown if there is an association between parasite DTUs and clinical
manifestations (Rassi et al. 2010).
There are four proposed subgroups within the TcI DTU, known as haplotypes Ia, Ib, Ic,
and Id (Herrera et al. 2009). Research suggests that haplotype Ia is associated with the domestic
cycle and the vector R. proxilus, haplotype Ib is associated with humans, the peridomestic cycle,
the vector T. dimidiata, haplotype Ic is associated with the peridomestic cycle, and haplotype Id
is associated with the sylvatic transmission cycle (Herrera et al. 2009). A recent study reported
that TcIa was has been found in three different states in Mexico, including in T. dimidiata in the
Yucatan Penisula, in T. (Meccus) picturatus in Nayarit, and in an acute human case in Oaxaca
(Monteón et al. 2014). Several studies have observed TcI circulating in vectors in Jalisco.
However, haplotypes of TcI have not been previously identified (Magallón-Gastélum et al. 2004;
Magallón-Gastélum et al. 2006; Brenière et al. 2007; Brenière et al. 2010)
Distribution of T. cruzi DTUs
The distribution of DTUs is distinct in North, Central, and South America (Fig. 3). TcI is
the dominant strain (60% of the overall identifications) and frequently observed in sylvatic
cycles but also in the domestic cycle throughout the Americas (Brenière et al. 2016). TcI and
TcIV are the only DTUs reported in Central America (Higo et al. 2004; Ruíz-Sánchez et al.
2005; Iwagami et al. 2007; Brenière et al. 2016). In contrast, all DTUs have been detected in
South America (Brenière et al. 2016). In the southern cone, TcII, TcV, and TcVI were proposed
as the main agents of T. cruzi infection in domicilary transmission, whereas TcIII and TcIV were
only occasionally found in humans (Brenière et al. 2016). In North America, all DTUs have been
detected except TcVI and Tcbat (Brenière et al. 2016).
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Fig. 3. Distribution of T. cruzi DTUs in North, Central, and South America (Brenière et al. 2016)
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Abstract
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi, which is
transmitted to domestic and sylvatic mammals via the feces of hematophagous hemiptera of the
subfamily Triatominae (Reduviidae). Trypanosoma cruzi is found only in the Americas and
displays remarkable genetic diversity. Seven discrete typing units (DTUs) are currently
recognized (TcI–TcVI and TcBat). In Jalisco, Mexico, where Chagas disease has a high
prevalence rate, TcI has historically been the only DTU reported. This study focused on the
molecular identification of T. cruzi DTUs circulating in Triatoma near the Estación de
Biología Chamela, on the southwest coast of Jalisco, Mexico. We collected DNA from 95
Triatoma bugs. Trypanosoma cruzi infection was detected using PCR primers specific for the
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minicircle variable region of the parasite’s kinetoplast DNA (kDNA). Trypanosoma cruzi DTUs
were identified by amplifying the intergenic region of the mini-exon, and the genes 24Sα, 18S,
TcSC5D, and TcMK. Two species of Triatoma were collected, Triatoma longipennis and T.
bolivari, with an overall infection rate of 59%. There was high genetic diversity of T. cruzi in our
samples, with the DTUs TcI, TcII, TcIV, TcVI, and Tcbat being identified. This is the first report
of TcVI and Tcbat in North America. In the Triatoma found to be infected, 96% had TcI, 35%
TcII, 2% TcIV, 25% TcVI, and 2% Tcbat. Several vertebrate hosts for Triatoma were also
identified from visible blood within Triatominaes’ gut using PCR primers for cytochrome b and
cytochrome oxidase subunit I genes. Our observations indicate a much higher diversity of T.
cruzi DTUs in Triatoma than previously reported in Jalisco. The results have important
implications for understanding the geographical distribution of T. cruzi DTUs and epidemiology
of Chagas disease in Mexico.
Keywords: Trypanosoma cruzi, Genotyping, Discrete typing units (DTUs), Triatoma
longipennis, Triatoma bolivari, Seasonally dry tropical forest, Jalisco, Mexico
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Introduction
Chagas disease (American trypanosomiasis) is caused by infection with Trypanosoma
cruzi, a parasitic protozoan found in over 180 species of mammals wherever Triatominae insect
vectors are found, between approximately 40o N and S of the equator in the Americas ("Who,
how, what and where ?" 2010). Chagas disease is responsible for disability and early death in
approximately one-third of those infected (Carabarin-Lima et al. 2013). The WHO reports that
approximately 5-6 million individuals are infected with Chagas disease, more than 25 million at
risk, and 10,000 die each year in endemic areas (WHO 2010; 2015). Chagas disease has been
increasingly detected in the US, Canada, and many European and Asian countries due to human
migration between Latin America and the rest of the world (Coura and Viñas 2010). Although
the vector does not live outside of the Americas, the risk of blood-borne transmission and burden
of health care for those with chronic Chagas disease makes T. cruzi a global threat to public
health.
In Mexico, it is estimated that 1.1 to 2 million people are infected with Chagas disease,
predominately through vector-borne exposure (Carabarin-Lima et al. 2013). Human infections in
Mexico come from both domestic and sylvatic transmission (Carabarin-Lima et al. 2013).
Trypanosoma cruzi infection has also increasingly been transmitted via blood transfusion
(Carabarin-Lima et al. 2013), although mandatory serological screening nationwide is reducing
this risk (Sánchez-González et al. 2016). In addition, there is no consensus on diagnostic
methods and trypanocidal treatment is not administered to chronic patients (Carabarin-Lima et
al. 2013). The disease is also becoming more urbanized likely due to human migration from rural
areas to Mexican cities, mostly in search of jobs (Carabarin-Lima et al. 2013). There are 18
regions in Mexico, all rural, that have endemic T. cruzi transmission, including the states of
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Oaxaca, Jalisco, Yucatan, Chiapas, Veracruz, Puebla, Guerrero, Hidalgo, and Morelos
(Carabarin-Lima et al. 2013).
The hematophagous triatomine vectors of T. cruzi include several species of the
subfamily Triatominae (family Reduviidae) in 3 genera (Triatoma, Rhodnius, Panstrongylus). At
least 31 species of Triatoma have been reported in Mexico with the most important vectors being
T. barberi, R. prolixus, T. dimidata, T. gerstaekeri, T. longipennis, T. mazzotti, T. mexicana, T.
pallidipennis, T. phyllosoma, T. picturata, and T. rubida (Ramsey et al. 2015). Control of
Triatominae vectors in countries where domestic Chagas disease occurs primarily involves
insecticide treatment of homes to reduce infestation. This has been shown to be the most cost
effective option to control domestic Chagas disease (Coura and Dias 2009; Vazquez-Prokopec et
al. 2009; Waleckx et al. 2014). In Mexico, where the majority of transmission is believed to be
due to transient seasonal infestations from adult Triatoma dispersals from sylvatic habitats to
human dwellings, the effectiveness of yearly treatment has not been studied (Waleckx et al.
2014). However, current control programs for mosquitoes to prevent Dengue transmission could
potentially reduce Triatoma in residential areas (Carabarin-Lima et al. 2013).
Trypanosoma cruzi was originally assigned to two major lineages, T. cruzi I (TCI) and T.
cruzi II (TCII). TCII was further subdivided into five groups: IIa, IIb, IIc, IId, and IIe (Zingales
et al. 2009). Recently, the lineages have been revised and classified into seven discrete typing
units (DTUs), namely TcI (TCI), TcII (IIb), TcIII (IIc), TcIV (IIa), TcV (IId), TcVI (IIe), and the
most recently proposed Tcbat (Zingales et al. 2009). TcV and TcVI are hybrids of TcII and TcIII
(Zingales et al. 2012). These hybrids may have arisen from two independent recombination
events or a single incidence of hybridization followed by clonal divergence (Lewis et al. 2011).
It has been suggested that different DTUs cause different disease pathology of Chagas disease,
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but it is unknown if there is an association between parasite DTUs and clinical manifestations
(Messenger et al. 2015).
Within TcI there is additional genetic diversity or haplotypes. The most commonly
employed method for determining the haplotype of T. cruzi DTUs is based on genetic variability
of the intergenic region of the mini-exon (Souto et al. 1996). By analyzing the intergenic region
of the mini-exon, it is possible to determine four subgroups of TcI DTU, known as haplotypes Ia,
Ib, Ic, and Id (Herrera et al. 2009). TcIa has been found in eastern Mexico but haplotype studies
have not been undertaken in Jalisco (Monteón et al. 2014).
The dominant strain of T. cruzi in Mexico is TcI (Bosseno et al. 2002; Brenière et al.
2007), but recent studies have indicated other DTUs (TcII, III, IV, V) circulating in Triatominaes
in Veracruz and Michoacán, Mexico (Ramos-Ligonio et al. 2012; Ibáñez-Cervantes et al. 2013).
One study also reported many patients in Mexico were seropositive for TCII, which includes
DTUs TcII-VI (Risso et al. 2011). These studies suggest either that the diversity of T. cruzi
strains in Mexico is growing, or increased sampling has led to a better understanding of the
complexity of DTUs within Mexico. Jalisco has the highest prevalence of T. cruzi infection in
Mexico, as 12% of the population was found to be seropositive (Carabarin-Lima et al. 2013), and
only TcI has been previously reported there (Bosseno et al. 2002; Brenière et al. 2007).
However, Jalisco is adjacent to Michoacán, where multiple T. cruzi DTUs have been identified
(Ibáñez-Cervantes et al. 2013). Given these findings, Jalisco could potentially have greater
diversity of T. cruzi DTUs than previously reported. A recent survey showed that Jalisco is one
of 10 Mexican states that have greatest risk for human exposure to infected Triatominae (Ramsey
et al. 2015).
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Our study explores the prevalence and diversity of potential T. cruzi DTUs within their
sylvatic Triatoma insect vectors inhabiting a tropical dry forest reserve in coastal Jalisco,
Mexico. Our objectives were to (a) evaluate the prevalence of T. cruzi in the local Triatominae,
(b) determine the T. cruzi DTUs and haplotypes present in the region, (c) identify Triatominae
vectors encountered near Estación de Biología Chamela (EBCh) in Jalisco, Mexico, and (d)
when possible, determine which vertebrates are serving as hosts for Triatominae.
Materials and Methods
Study site
The Estación de Biología, Chamela (EBCh) is an ecological reserve and research station
located in Jalisco in western Mexico (19º30'N, 105º03'W). The field station, owned and managed
by the Universidad Nacional Autónoma de México (UNAM), is situated on 3,319 ha of
undisturbed seasonally dry tropical forest (SDTF) and surrounding by an additional 13,142 ha of
forest comprising the Chamela-Cuixmala Biosphere Reserve, one of few SDTFs protected areas
on the planet (Ceballos 1995; Dirzo et al. 2011). The climate is highly seasonal, characterized by
a pronounced dry season (Nov – Jun) and a 4-mo wet season (Jul – Oct) during which 80% of
annual precipitation falls (Bullock 1986). From 1978 to 2015, mean annual precipitation was
829mm (range 300 – 1,300 mm; UNAM, EBCh meteorological data archives).
Collection and identification of triatomines
A total of 95 specimens were analyzed in this study. Triatoma were collected at three
different periods during 2014- 2015 at EBCh. Eighteen Triatoma in our sample were captured in
pitfall traps, initially installed in the Chamela forest for capturing lizards (García and Cabrera
Reyes 2008), but which also proved to be useful in trapping Triatoma in this study. Several
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Triatominaes were also collected by hand at EBCh due to their attraction to light (lit buildings
and windows). All insects were euthanized by placing in -20ºC freezer for one hour.
Extraction of Triatoma DNA
Triatomines’ hindgut contents were placed on FTATM cards (GE Healthcare) to render
any parasites non-infectious and to preserve DNA samples (Rogers and Burgoyne 1997; Kraus et
al. 2011). Triatomines that were previously stored in 100% ethanol or dried were processed by
macerating the abdomen in 500 µl distilled water followed by three cycles of freezing at -20ºC
and thawing at room temperature before placing the mixture onto FTATM card. For a 25 l PCR
reaction mixture, a 2 mm disc of the FTA card was cut out using Disposable Biopsy Punches,
Integra™ Miltex® (Integra LifeScience). Prior to PCR, FTA discs were washed with FTA
Purification Reagent (GE Healthcare) according to the manufacturer’s instruction.
Diagnostic PCR
In this study, all amplification products were generated in a 25 l reaction mixture
containing a 2mm FTA disc, 0.2 M of each primer, 12.5 µl of Apex Taq RED Master Mix
(Genesee Scientific) and Nanopure™ Ultrapure H2O, and generated in a C1000TM Thermal
Cycler (Bio-Rad). All amplification products were separated on either TAE or TBE-agarose gel
(Agarose GP2, MidsciTM) with ethidium bromide and were visualized under UV light. Negative
and positive controls (CL Brener, ATCC®) were carried out for all DNA samples.
Since Triatominae can be infected with either T. cruzi and/or Trypanosoma rangeli, all
samples were subjected to PCR analysis using the primers TE and TR which are specific for T.
rangeli (Fernandes et al. 2001) and amplify a 100 bp mini-exon PCR product (Table 1).
Amplification products were separated on 2% TAE-agarose gel. To detect T.cruzi DNA, a
diagnostic PCR was performed on all samples by amplifying the minicircle variable region of the
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kinetoplast DNA (kDNA) using primers 121 and 122 (Table 1) (Cardoso et al. 1994). Samples
that showed the diagnostic 330 bp fragment were considered T. cruzi-positive and were selected
for molecular identification of T. cruzi DTUs.
Table 1 Primers, annealing temperature, and amplicon size used for identification of T.cruzi DTUs,
triatomines, and blood meal source
Target gene

T. rangeli

Non-transcribed TR
spacer region of TE
mini-exon
Variable region 121
of mini-exon
122

CCT ATT GTG ATC CCC ATC TTC G
TAC CAA TAT AGT ACA GAA ACT G

50

100 bp

(Fernandes et
al. 2001)

AAA TAA TGT ACG GGK GAG ATG CAT GA
GGT TCG ATT GGG GTT GGT GTA ATA TA

57

330 bp

(Cardoso et
al. 1994)

T. cruzi

Intergenic
TC1
region of mini- TC2
exon
TC

GTG TCC GCC ACC TCC TTC GGG CC
CCT GCA GGC ACA CGT GTG TGT G
CCC CCC TCC CAG GCC ACA CTG

55

T. cruzi

TcSC5D

TcSC5D-fwd
TcSC5D-rev

GGA CGT GGC GTT TGA TTT AT
TCC CAT CTT CTT CGT TGA CT

58

832 bp

T. cruzi

TcMK

TTT TTG CAT GTC ATT TTG G
AGC GGT CTT GTA ATG AGC AC

58

637 bp

T. cruzi

24Sα

Tc-Mevkinase26-Fw
Tc-Mebkinase662-Rv
D71
D72

AAG GTG CGC GAC AGT GTG G
TTT TCA GAA TGG CCG AAC AGT

60

T. cruzi

18S

V1
V2

CAA GCG GCT GGG TGG TTA TTC CA
TTG AGG GAA GGC ATG ACA CAT GT

60

Vertebrate
mtDNA cyt b
Triatoma sp.

Forward-cytb
Reverse-cytb

GAG GMC AAA TAT CAT TCT GAG G
TAG GGC VAG GAC TCC TCC TAG T

50

457 bp

(Mehus et al.
2013)

Vertebrate

ForwardCOI_long
ReverseCOI_long
LCO1490
HCO2198

AAC CAC AAA GAC ATT GGC AC
AAG AAT CAG AAT ARG TGT T

50

663 bp

(Mehus et al.
2013)

GGT CAA CAA ATC ATA AAG ATA TTG G
TAA ACT TCA GGG TGA CCA AAA AAT CA

50

710 bp

(Folmer et
al. 1994)

T. cruzi

mtDNA COI

Triatoma sp. mtDNA COI

Primer name

5’-3’ Primer sequence

Target
organism

Anneal Amplicon
ºC
size

see table 2 (Souto et al.
1996)
(Cosentino
and Agüero
2012)
(Cosentino
and Agüero
2012)

see table 2 (Souto and
Zingales
1993)
see table 2 (Clark and
Pung 1994)

Molecular identification of T. cruzi DTUs
Trypanosoma cruzi genotyping was accomplished using two different methods. In the
first method, we analyzed three gene fragments of T. cruzi: the intergenic region of the mini-
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Ref.

exon, and the genes 24Sα and 18S. Table 2 summarizes the expected size of amplification
products. In the second method, we targeted the gene fragments of TcSC5D (putative
lathosterol/episterol oxidase) and TcMK (mevalonate kinase) of T. cruzi (Cosentino and Agüero
2012).
Table 2 PCR amplification scheme and expected DNA fragments of different T. cruzi DTUs
TcI
TcII TcIII
TcIV
TcV
300
300
Mini exon (TC, TC1 and TC2 primers) 350
110
125
110
120,125,130* 100, 125
24Sα rRNA (D71 and D72 primers)
175
165
165
155
155
18S rRNA (V1 and V2 primers)
*TcIV could have either 120, 125 or 130 bp (Brisse et al. 2001; Ramos-Ligonio et al. 2012)
PCR amplification of the mini exon intergenic region: Multiplex PCR, using the primer
set TC1, TC2 and TC, was used to amplify the mini-exon intergenic region (Souto et al. 1996).
Amplification products were separated on 2% TAE-agarose gel. PCR amplification produced a
350bp fragment for TcI and/or 300bp for DTUs TcII, TcV, and TcVI.
PCR amplification of the 24Sα: DTUs TcII, TcV, and TcVI were detected by
amplification of 24Sα rRNA using primers D71 and D72 (Souto and Zingales 1993).
Amplification products were separated by on 3% TAE-agarose gel due to small amplicon size.
24Sα PCR amplified 125 bp fragment from TcII, 110 bp fragment from TcIII, 120, 125, and 130
bp fragments from TcIV, 110 and 125 bp fragments from TcV, and 125 bp fragment is produced
from TcVI (Table 2).
PCR amplification of the 18S: DTUs TcIII and TcIV both produce a 125 bp 24Sα PCR
product, therefore the DTUs were distinguished by amplification of the gene encoding 18S rRNA
using the primers V1 and V2 (Clark and Pung 1994). Amplification products were separated on
3% TAE-agarose gel. 18S PCR amplified a 165 bp fragment from TcII, and no fragment is
produced from TcVI (Table 2).
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TcVI
300
125
-

DTU determination using the TcSC5D and TcMK genes: Cosentino and Agüero (2012)
proposed a simple typing assay for determining T. cruzi DTUs that requires a single PCR
amplification followed by either restriction enzyme digest or a direct sequencing assay.
Amplification protocols for TcSC5D and TcMK were carried out according to the published
protocol (Cosentino and Agüero 2012). TcSC5D gene fragments were used to determine DTUs
TcI, TcII, TcIII, TcIV and Tcbat. TcMK fragments were used to determine TcV and TcVI. PCR
was followed by enzyme digestion as described by Cosentino and Aguero (2012). Prior to
enzyme digestion, PCR products were purified using DNA Clean & Concentrator-5 Kit (Genesee
Scientific). A sample of 20 µl of purified TcSC5D PCR products were digested with 1 U of HpaI
(NEB R0105) and 1 U SphI (NEB R0182) at 37ºC for 1 h. Digestions were performed in the
CutSmart buffer (NEB B7204S). The digested fragments were resolved in 2% TBE-agarose gels.
For TcMK gene, 20 µl of the purified TcMK PCR products were digested with 1 U of XhoI (NEB
R0146) at 37ºC for 1 h. The digested fragments were resolved in 2.5% TBE-agarose gels.
Identification of Triatominaes
Identification of Triatoma found at EBCh involved using a dichotomous key (Lent and
Wygodzinsky 1979), comparison to specimens deposited in the national collection of insects in
the Institute of Biology, UNAM, and PCR analysis targeting a 457 bp region of mitochondrial
cytochrome b (cyt b) and a 710 bp region of the cytochrome oxidase subunit I (COI) genes
followed by sequencing (Table 1) (Folmer et al. 1994; Mehus et al. 2013). Two reference
samples of T. longipennis, male and female, were sent to UNAM for identification due to
difficulty with visual identification (Fig. 4).
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Fig. 4. Triatoma collected at Estación de Biología, Chamela. a. Triatoma bolivari, male,
24.4mm in length, collected on July 5, 2015 outside the library at EBCh, b. Triatoma
longipennis, female, 35.5mm in length, collected on July 7, 2015 in a pitfall trap near Arroyo
Colorado in the Chamela-Cuixmala Biosphere Reserve, c. close-up of T. longipennis head,
corium, and pronotum, d. close-up of T. longipennis head and neck demonstrating yellow
markings on side of neck (arrow)
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The COI and cyt b genes of Triatominaes were PCR amplified, separated on 2% TAEagarose gel, and the corresponding PCR products were purified and submitted for sequencing.
The sequences were analyzed using the Basic Local Alignment Search Tool (BLAST) at
National Center for Biotechnology Information (NCBI, https://blast.ncbi.nlm.nih.gov/) to
identify similarity to Triatoma sequences.
Identification of Triatoma blood meals
To identify the origin of Triatoma blood meals, 12 samples containing bllod were
subjected to PCR analysis by targeting 457 bp region of cyt b genes, and a 663 bp region of the
COI gene (Table 1) (Mehus et al. 2013). Amplification products were separated on 1.5% TAEagarose gel, sequenced, and compared with deposited sequences in Genbank.
DNA Sequencing
The PCR products of the mini-exon intergenic region, 24Sα, 18S, TcSC5D, TcMK, cyt b
and COI genes were excised and recovered from agarose using Zymoclean Gel DNA Recovery
Kit (Genesee Scientific). The purified PCR products were sequenced by Genewiz, Inc (South
Plainfield, NJ) and GenScript, Inc (Piscataway, NJ) using ABI 3730 DNA Analyzer. DNA
sequences were manually aligned using BLAST, edited using BioEdit software and compared
with the sequences in GenBank using BLAST search to identify the parasite DTUs, Triatoma
and blood meals sources.
Results
T. cruzi detection in Triatoma specimens
Ninety-five adult triatomines were collected at EBCh or nearby areas in Jalisco, Mexico.
While collection efforts were attempted in the towns of Chamela and Emiliano Zapata no
Triatoma were found. This may be due to recent spraying for Dengue in both villages, or the
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non-domestication of local Triatoma. Two different species of Triatoma (Fig. 4) were found near
the biological station, 61 T. bolivari (10 females and 51 males) and 34 T. longipennis (21
females and 13 males). A majority of the T. bolivari were found near light sources around the
station, while the T. longipennis were predominately found in the forest.
The gut contents for all of the Triatoma collected were tested for the presence of
conserved domains of mini-exon or kinetoplastid minicircle DNA using PCR primers specific for
either T. cruzi or T. rangeli. Trypanosoma rangeli is non-pathogenic for mammals but causes
pathology in Triatominae of the genus Rhodnius, and can be confused for T. cruzi when
immunological test methods are used. T. rangeli are primarily seen in R. prolixus (Hoare 1972;
Azambuja and Garcia 2005), although T. rangeli has been found in Triatoma in Colombia
(Marinkelle 1968). None of the samples yielded T. rangeli amplicons of the non-transcribed
spacer of the mini-exon gene using the primers TR/ME. The mini-exon intergenic region is a
good target for PCR-based detection as there are over 200 tandem repeats each containing a
highly conserved 39-nt exon sequence (Campbell et al. 2003). Of the 95 samples in our study, 56
(59%) were positive for T. cruzi using the 121/122 kinetoplast minicircle PCR primers. Because
each parasite within an infected bug has thousands of 1.4 kb kinetoplast minicircles, the
minicircles are an ideal target for T. cruzi detection (Thomas et al. 2007). Of the T. bolivari
samples, 28 of 61(46%) were positive for T. cruzi and 28 of 34 T. longipennis samples (82%)
tested positive for the parasite.
The various T. cruzi DTUs that we identified in our Triatoma samples are shown in
Fig. 5. To identify T. cruzi, DTUs four different regions were targeted: 1) the mini-exon
intergenic region, 2) the 24Sα and 18S ribosomal genes, 3) the TcSC5D gene, and 4) the TcMK
gene. The limited amount of T. cruzi DNA that was preserved in samples on the FTA paper
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made amplifying single copy genomic DNA difficult. Therefore, multiple methods were
employed to differentiate DTUs from the 56 positive samples (Tables 3). Thirty of those samples
revealed a mini-exon intergenic region PCR product of 350 bp and were thus identified as
infected with only TcI (Table 4). One sample produced a PCR product of 300 bp that
corresponded to either TcII, TcV, or TcVI. Further analysis using the 24Sα and 18S genes
produced 125 and 165 bp products respectively identifying DTU TcII (1/56, 2%). One sample
showed neither a 300 bp nor a 350 bp of the mini-exon gene suggesting TcIII or TcIV. This
sample produced a 125 bp product of the 24Sα gene and a 155bp product of the 18S gene,
identifying it as TcIV (1/56, 2%).

Fig. 5 The distribution of T. cruzi DTUs in EBCh Triatoma. Each hatch mark represents an
individual Triatoma, boxes below the line represent the different DTUs found in each individual.
A. Out of 34 T. longipennis, 28 (82%) contained T. cruzi DTUs. B. Out of 61 T. bolivari 28
(46%) contained T. cruzi DTUs
Twenty-four of the 56 T. cruzi positive samples produced two products of 350 bp and 300
bp and therefore contained multiple DTUs. These samples with mixed infections of T. cruzi
DTUs were further analyzed using 24Sα and 18S ribosomal genes; however, most of the PCRs
produced amplification products of 110bp (24Sα) and 175bp (18S), which demonstrates only TcI
(Table 2). The amount of TcI DNA might be more abundant in samples with mixed infections, or
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the primers may preferentially amplify TcI over other DTUs, which would explain why the 24Sα
and 18S primers tended to pick up only the ribosomal genes from TcI.
Of the 56 positive samples, 35 amplified with primers TcSC5D-fwd/TcSC5D-rev, which
target the genomic single copy TcSC5D gene. We were not able to amplify the TcSC5D gene in
the remaining 31 positive samples because not enough T. cruzi DNA was preserved in the FTA
paper. Four different DTUs, TcI, TcIV, TcVI, and Tcbat, were found in the 35 samples using the
TcSC5D gene, a restriction enzyme digestion assay, and DNA sequencing (Table 3 and Table 4).
The DTUs TcV and TcVI are two independent hybrids that are derived from TcII and TcIII
(Zingales et al. 2012). Therefore, discrimination of TcV and TcVI by sequencing TcSC5D
amplification products does not identify the strain. By amplifying a different gene (TcMK) and
using a restriction enzyme assay we were able to distinguish between TcV and TcVI.
Considering the data together, 54 of 56 (96%) samples were infected with TcI, 20/56
(36%) with TcII, 14/56 (25%) with TcVI, 1/56 (2%) with TcIV, and 1/56 (2%) with Tcbat
(Fig. 5). Many of the infected Triatoma 24/56 (42%) contained mixed DTU populations.
DNA sequencing and data deposition
T. cruzi DTU identification was confirmed by sequencing of the mini-exon intergenic
region, and the TcSC5D and TcMK genes (Table 5). We were able to confirm haplotype TcIa in
all of the TcI positive samples. Sequence data also confirmed the PCR analysis for TcII, TcIV,
TcVI, and Tcbat.
Triatoma bolivari found at EBCh were identified from physical characteristics and by
sequencing the cyt b gene (Table 6). The cyt b gene of T. bolivari had a 91% identity with the
only reported cyt b T. bolivari sequence, which was collected at EBCh. There was also a 100%
identity with the COI gene of a Triatoma sp. deposited in the American Museum of Natural
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History, but this specimen had no location or species information. For T. longipennis, the COI
gene did not have high homology to any deposited sequences and the cyt b gene only had 87%
identity with a T. longipennis sequence on GenBank (Table 6).
Table 3 Molecular identification of T. cruzi DTUs and DNA sequencing suggest mixed
infections in triatomines
No of
Mini24S and
TcSC5D and
Total DTUs
#
samples
exon
18S
TcMK
Tl & Tb
11
TcI
TcI
TcI*
TcI
(n=30)
Tl & Tb
19
TcI
TcI
ND
T. bolivari
1
TcII
TcII
TcII**
TcII
(n=1)
T. longipennis
1
ND
TcIV
TcIV*
TcIV
(n=1)
T. bolivari
9
TcI, TcII
TcI
TcI*
TcI, TcII
(n=10)
Tl & Tb
1
TcI, TcII
ND
ND
Tl & Tb
3
TcI
TcI
TcI*, TcVI**
TcI, TcVI
(n=3)
T. bolivari
1
TcI
TcVI*
T. longipennis
2
TcI, TcII
TcI
TcI*, TcVI**
TcI, TcII, TcVI
(n=9)
7
TcI, TcII
TcI**,TcVI*
T. longipennis
1
TcI
TcI
Tcbat*, TcI**,
TcI, TcVI, Tcbat
TcVI**
(n=1)
*Parasite DTUs were confirmed by both enzyme digestion assay and DNA sequencing results
**Parasite DTUs were confirmed by enzyme digestion assay only
#
TcMK gene used for TcV and TcVI discrimination
Tl & Tb = T. longipennis and T. bolivari
ND = no data was obtained
Table 4 Frequency of T. cruzi DTUs and mixed infections in triatomines
Single and mixed infection frequency
Triatomines
TcI
TcII TcIV
TcI,
TcI,
TcI, TcII,
only
only
only
TcII
TcVI
TcVI
T. longipennis (n=28)
11
1
5
1
9
T. bolivari (n=28)
19
1
5
3
Total (n=56)
30
1
1
10
4
9
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TcI, TcVI
Tcbat
1
1

Table 5 GenBank accession numbers of TcSC5D, TcMK, and Mini-exon sequences of T. cruzi DTUs
T. cruzi
DTUs

TcSC5D

TcMK

Mini-exon

TcI #

KX858838*

CP015687 (99%)
JN050565 (99%)

-

-

KX858836*

AM259467 (TcIa) (99%)
AM259469 (TcIb) (97%)
AM259474 (TcIc) (96%)
AM259473 (TcId) (94%)

TcII

KX987101*

JN050574 (99%)
JN050569 (99%)

-

-

KX858837*

KM376439 (99%)
KM376435 (99%)

TcIV

KX858839*

-

-

-

-

TcVI

KX858840*

JN050564 (99%)
JN050568 (99%)
XM_797152 (100%)
JN050576 (93%)

KR350585 (99%)
XM_797435 (99%)

-

-

Tcbat

KX858841*

-

-

KX874594*

TCC1122 (99%)

-

% identity to deposited sequences in GenBank is provided in parenthesis.
*Sequences were obtained in this study.
# Haplotype TcIa was identified by DNA sequence of mini-exon.
Triatoma bolivari found at EBCh were identified from physical characteristics and by
sequencing the cyt b gene (Table 6). The cyt b gene of T. bolivari had a 91% identity with the
only reported cyt b T. bolivari sequence, which was collected at EBCh. There was also a 100%
identity with the COI gene of a Triatoma sp. deposited in the American Museum of Natural
History, but this specimen had no location or species information. For T. longipennis, the COI
gene did not have high homology to any deposited sequences and the cyt b gene only had 87%
identity with a T. longipennis sequence on GenBank (Table 6).
Table 6 GenBank accession numbers of cyt b and COI sequences of Triatoma.
Triatoma sp.
Triatoma bolivari

Triatoma longipennis

Cyt b

COI

KY193790*

JQ282718
(91% T. bolivari)

KY033219*

AY252963
(100% Triatoma sp.)

KY033227*

JN5858554
(91% T. dimidiata)
DQ198815
(87% T. longipennis)

KY033220*

KC249392
(76% T. vandae)

% identity to deposited sequences in GenBank is provided in parenthesis.
*Sequences were obtained in this study.
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Twelve Triatoma had visible blood within their gut contents. The blood meal source was
identified by amplifying the cyt b and COI genes. The DNA sequences were queried for similar
sequences using NCBI’s nucleotide BLAST search. Table 7 contains the percent identity of the
various blood meal sources and their accession numbers. Of the twelve Triatoma containing
visible blood, we were able to obtain cyt b and COI sequences for eleven samples (Table 7). One
sample had a low match (81%) for cyt b, but a 100% match for COI of Gallus gallus. One
sample had 96% match for cyt b of Sciurus aureogaster, but we were not able to compared COI
sequence of S. aureogaster to other sequences since it is not available on GenBank.
Table 7 Identification of the triatomines’ blood meals using cyt b and COI genes.
Triatoma sp.

T. longipennis

T. bolivari

#

T. cruzi
DTUs

2

TcIa

1

TcIa, TcII

1

TcIa

1

TcIa, TcII

1

TcIa, TcII

2

N/A

1

TcIa

1

TcIa,
TcVI
TcIa

1

Accession #

Blood meal sources
White-tailed deer
(Odocoileus virginianus)
Marble toad
(Incilius (Bufo) marmoreus)
Dog (Canis familiaris)
Human (Homo sapiens)
Dog (Canis familiaris)
Mexican gray squirrel
(Sciurus aureogaster)
Human (Homo sapiens)
Chicken (Gallus gallus)

Cyt b

COI

KX874595*

KM612275 (99%)

KY033224*

JN632673 (99%)

KX874599*

HM563957 (99%)

KY033223*

JN867979 (99%)

KX874598*

KU291082 (99%)

KY033225*

KU696410 (100%)

KX874596*
KX874598*

AP008916 (100%)
KU291082 (99%)

KY033221*
KY033225*

KT725864 (100%)
KU696410 (100%)

KX874597*

KC737847 (96%)

KY033226*

-

KX874596*

AP008916 (100%)

KY033221*

KT725864 (100%)

KY084833*

EF076670 (81%)

KY033222*

KT780168 (100%)

% identity to deposited sequences in GenBank is provided in parenthesis.
*Sequences were obtained in this study.
Discussion
T. cruzi infection rate at EBCh
We found many Triatoma infected with T. cruzi within EBCh, with an overall infection
rate of 59% (82% of T. longipennis and 46% of T. bolivari). Previous studies reported the T.
cruzi prevalence in Triatoma from Jalisco to range from 46-57%, a result similar to ours
(Magallón-Gastélum et al. 2004; Brenière et al. 2007; Brenière et al. 2010). The very high
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infection rate observed in T. longipennis (28/34 or 82%) may be an artifact of small sample size
and further collection will provide a clearer estimate of the prevalence of T. cruzi in this
Triatominae.
High diversity of T. cruzi DTU at EBCh
The diversity of T. cruzi DTUs has not been thoroughly investigated in Jalisco; only TcI
has previously been reported (Bosseno et al. 2002; Brenière et al. 2004; Magallón-Gastélum et
al. 2004; Magallón-Gastélum et al. 2006; Brenière et al. 2007; Walter et al. 2007; Brenière et al.
2010). Our findings indicate there is greater diversity of T. cruzi DTUs than previously reported.
This is in agreement with studies from other states in Mexico that indicate high frequencies of
non-TcI strains. TcIII, TcIV and TcV were observed in Veracruz (12-27% each) (Ramos-Ligonio
et al. 2012) and TcII, TcIII, and TcIV were found in Michoacán (6-20% each) (Ibáñez-Cervantes
et al. 2013).
In our study, TcI, and in particular the haplotype TcIa, was found in 96% of infected
Triatominae. This result suggests that TcIa is the dominant strain circulating in mammals in
coastal Jalisco. Several studies have observed TcI circulating in vectors in Jalisco; however,
haplotypes of TcI have not been previously identified (Magallón-Gastélum et al. 2004;
Magallón-Gastélum et al. 2006; Brenière et al. 2007; Brenière et al. 2010). Our study confirms
the presence of the haplotype TcIa in Jalisco. A recent study reported that TcIa was also found in
three different states in Mexico, including in T. dimidiata in the Yucatan Pennisula, in T.
(Meccus) picturatus in Nayarit, and in an acute human case in Oaxaca (Monteón et al. 2014).
The distribution of DTUs is distinct in North, Central, and South America. TcI and TcIV
are the only DTUs reported in Central America (Brenière et al. 2016). In contrast, all DTUs have
been detected in South America. In the southern cone, TcII, TcV, and TcVI were proposed as the
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main agents of T. cruzi infection in domicilary transmission, whereas TcIII and TcIV were only
occasionally found in humans (2010; Brenière et al. 2016). TcI was frequently observed in
sylvatic cycles but also in the domestic cycle throughout the Americas (Brenière et al. 2016). In
North America, all DTUs have been detected, except TcVI and Tcbat (Brenière et al. 2016).
However, our findings now confirm the presence of TcVI and Tcbat in North America.
The high diversity of DTUs in a small area could be attributed to human and animal movement.
It is unknown if the high DTU diversity observed is novel to Mexico, or due to increased
surveillance. If the non-TcI DTUs are due to migration, visiting scientists at EBCh may be
contributing to the novel DTUs seen near the biological station. It would be interesting to see if
sampling other locations in costal Jalisco would yield the same high diversity as in our study at
EBCh. The high volume of traffic moving along Coastal Mexican Federal Highway 200
(Carretera Federal 200) through the biological reserve also contributes to the possibility that high
diversity might be due to migration through the region, complicating understanding of which
strains are historically found in Jalisco versus imported DTUs.
First report of DTUs TcVI or Tcbat in North America
To our knowledge, this is the first report of either TcVI or Tcbat being detected in North
America (Brenière et al. 2016). TcVI was found in 25% (14/56) of the Triatoma with T. cruzi.
Because of this relatively high prevalence, our finding suggests that TcVI is likely well
established in the forest surrounding EBCh. TcVI has been reported throughout South America
from Argentina to northern Colombia (Messenger et al. 2016). In the southern cone region, TcVI
is associated with domestic transmission cycles where severe chronic Chagas disease and
congenital transmission are prevalent (Bern et al. 2011; Messenger et al. 2015). If TcVI is new to
Mexico, this strain could change the disease dynamics in a country that has enjoyed relatively
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little chronic Chagas disease despite the abundance of infected Triatoma (Bern et al. 2011;
Messenger et al. 2015).
Tcbat, considered to be a bat-exclusive lineage of T. cruzi, has not been reported north of
Panama (Brenière et al. 2016). Tcbat was described from Brazilian bats showing unique patterns
of ribosomal and spliced leader PCRs not clustering into any of the other six DTUs (Cavazzana
et al. 2010; Ramírez et al. 2014; Lima et al. 2015). Tcbat has been reported in bats in from Brazil
to Panama (Brenière et al. 2016), in a 5 year old girl living in northwestern Columbia (Ramírez
et al. 2014), and even in mummies from Chile (Guhl et al. 2014). Tcbat is closely related to TcI
and can be mistaken for TcI using standard molecular identification (Lima et al. 2015). The
identification technique we used allows us to distinguish Tcbat from other DTUs by targeting a
single molecular marker, the TcSC5D gene (Cosentino and Agüero 2012). While we only
encountered one T. longipennis harboring Tcbat, 33 species of bats (7 families) inhabit the
forests surrounding the field station (Ceballos and Miranda 2000). Given the high diversity of bat
species in the region, it is not surprising to find Tcbat in our Triatoma sample. There is evidence
of bat species Glossophaga soricina, Mormoops megalophylla, and Pteronotus parnelli infected
with T. cruzi in Jalisco (Sánchez-Cordero et al, unpublished).
Triatoma at EBCh
We only encountered two species of Triatominae at EBCh, identified as T. bolivari and T.
longipennis (Figure 1). Several other Triatominae that transmit T. cruzi have been reported in the
state of Jalisco including T. barberi, T. brailovskyi, T. dimidiata, T. phyllosoma, T. pallidipennis,
and T. mazzotti (Ramsey et al. 2015). Triatoma are known to have high genetic variability,
which may be due to their continuous domestication process and fragmentation of habitats
(Espinoza et al. 2013).
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The T. bolivari were identified by physical characteristics and the cyt b gene sequence,
which had a 91% match to a T. bolivari sequence collected at EBCh (Table 6) (Espinoza et al.
2013). Little work has been done on this Triatoma and few specimens have been collected. The
initial report of the species, T. bolivari, was from a specimen collected in coastal
Jalisco (Carcavallo et al. 1987). GeneBank only has 6 sequences reported to be from T. bolivari.
The only study that has looked at their genetic diversity suggests that there is little diversity
within this group, which is not consistent with the relatively low 91% identity for cyt b reported
here (Espinoza et al. 2013).
Triatoma bolivari has been considered to be of low epidemiological importance (Ramsey
et al. 2000). However, our study found 46% of T. bolivari infected with T. cruzi and most were
collected near outdoor lights or inside EBCh buildings. We also identified human blood in a T.
bolivari found inside the Library at EBCh. Light attraction by triatomines is believed to be a
potential factor of infestation, which leads to higher chance of T. cruzi infection (Zeledón 1983;
Rebollar-Téllez et al. 2009). Triatoma bolivari may be a strictly sylvatic species; adults attracted
by human light sources are unable to colonize buildings. Martinez-Ibarra et al (2010)
hypothesized that this species may be associated with birds rather than rodents. Our study found
the predominant blood source in T. bolivari (3 of 5 triatomines with blood present) was the
Mexican gray squirrel (Sciurus aureogaster). More research is needed to understand potential
hosts and the role T. bolivari as a vector. However, it appears T. bolivari has disappeared from
environmentally disturbed areas where it was previously reported and is now confined to coastal
areas in western Mexico (Ramsey et al. 2000; Martinez-Ibarra et al. 2010).
Two reference samples of T. longipennis, male and female, were sent to UNAM for
identification due to physical characteristics not matching reported Triatoma. The COI sequence
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showed no significant homology to T. longipennis sequences found in GenBank. The highest
homology was only 76% identity to Triatoma vandae (Table 6), a species from Brazil. We also
sequenced the cyt b gene and found 87% sequence identity with deposited T.
longipennis sequences, and 91% identity to T. dimidiata. Morphologically, the species we are
calling T. longipennis is distinct from T. dimidiata. The Phyllosoma complex species, including
T. longipennis, are reported to have large genetic variations making it difficult to distinguish
species using molecular techniques. The relationships are further complicated by the ease of
hybridization between species. We have called this species T. longipennis due to identification
by UNAM despite the lack of sequence data to support this identification.
Blood meal sources
We targeted the cyt b and COI genes to identify the blood meal source when blood was
observed in the gut contents of Triatominae. We were able to identify several blood meal sources
from 11 samples, including Homo sapiens, Odocoileus virginianus, Sciurus aureogaster, Canis
familiaris, Gallus gallus, and Incilius (Bufo) marmoreus (Table 7). All of these species are found
in the study area (Myska 2011). Only two of the Triatoma with blood meal source data were
negative for T. cruzi, both contained Mexican gray squirrel (Sciurus aureogaster) blood.
Not all of the Triatoma hosts identified through blood meal analysis are potential
reservoirs of T. cruzi. Over 180 domestic and wild mammals, primarilay marsupials, xenarthras,
bats, carnivores, lagomorphs, rodents, and primates, serve as hosts for T. cruzi (Carabarin-Lima
et al. 2013). While many vertebrates can provide a blood meal for Triatoma, only mammals are
known to support T. cruzi. The ability to survive in mammals is due in part to the parasite’s
expression of complement inhibitors to subvert innate immunity (Tambourgi et al. 1993; Norris
1998; Atayde et al. 2004; Cestari et al. 2008). Birds are known to be refractory to T. cruzi
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infection owing to complement-mediated lysis of the parasite, as T. cruzi’s complement
inhibitors are mammalian-specific (Kierszenbaum et al. 1981). Therefore, while bird and
amphibian blood was found in the Triatoma at EBCh, these animals are not contributing to T.
cruzi transmission.
FTA paper
There are many advantages to collecting Triatoma gut contents and preserving the DNA
on FTA paper. It protects DNA from degradation at room temperature and inactivates pathogens
for safe handling. However, we found that storing the DNA of Triatominae on FTA paper is not
optimal for PCR analysis. The amount of T. cruzi DNA retained on the FTA paper was
considerably less than when DNA was extracted from a whole Triatoma and the distribution of
DNA on the card was uneven. In addition, genomic DNA of T. cruzi is less abundant than
kDNA, which made it difficult to amplify genomic sequences from T. cruzi’s 24S, 18S,
TcSC5D and TcMK genes. In the future, Triatominae samples should be preserved in 70% EtOH
and whole specimens used for DNA extraction to maximize the DNA sample for analysis.
Potential risk of T. cruzi infection via wildlife
The high rates of infection of Triatoma leads to a concern of increased risk for people
using wildlife as a protein source in the state of Jalisco. If an infected mammal is butchered in
the field, there is a potential for transmission of the parasite from blood-borne exposure through
open cuts or from blood spatter on mucus membranes. Little research has been published
concerning T. cruzi transmission via hunting (Bern et al. 2011). Nevertheless, infection is a real
risk, especially to those who skin and process wildlife meat themselves (Bern et al. 2011) and to
those who feed on wildlife inhabiting lowland tropical deciduous forest in the region. Chagas
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disease should be addressed to the community through public outreach efforts to avoid T. cruzi
infection.
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